the second opinion

Exchange Watch: Are New Yorkers getting a bargain?

The state announces a big win on health policy prices, but a closer look is in order
July 18, 2013

Hallelujah! New York’s insurance exchange–kept under wraps for months by the administration of Gov. Andrew Cuomo–has finally brought forth some information about the rates that health insurers will charge New Yorkers next year. What a story this has become, beginning with what appeared to be a leak to The New York Times in Wednesday’s paper in advance of a press release from the governor’s office. The Times ran the news with an A1 leader and a dramatic headline: “Health Plan Cost for New Yorkers Set to Fall 50%.”

Twitter was ablaze, with Obamacare advocates quickly cheering the great news. Igor Volsky, the managing editor of ThinkProgress.org, was particularly prolific. A sample of his tweets: “NYT story on NY health premiums falling as a result of Obamacare is on A1. Haven’t seen in other NY papers yet,” and “Will be interesting to see how much coverage NY premium rates get since producers/editors always play up the anti Obamacare stories.” Matt Yglesias of Slate tweeted “An ObamaCare triumph for New York State.” He carried on his commentary in a muddled post called “The New York Obamacare Triumph and Why It matters.” The New York exchange and the governor couldn’t have asked for a better debut.

But a closer look is in order.

Karan Chhabra, who writes for Project Millennial, a site that is gaining a reputation for incisive looks at health policy, tweeted a caution: “Read NYT NYS Insurance article to the end. Underlying reason (guaranteed issue w/o mandate not true in other states.” To explain a bit: For months, actuarial experts had been predicting that rates would fall in New York–and in other states that already had tight insurance regulation that mirror what the Affordable Care Act calls for in January. Obamacare requires insurance to reach certain standards. New York and a few other states are already there.

Most states currently are not. Jim O’Connor, an actuary at the consulting firm Milliman, told me those who live in states like Ohio or Indiana–where regulators have used a softer approach–will see higher rate increases than those in New York and New England, where rates are already higher because of tougher state regulation. New York already required carriers to insure all applicants no matter how sick they are, and those people generate high claims. The state also already uses community rates–meaning the old and the young pay the same for coverage. That has also meant that New York had higher overall insurance rates.

Higher premiums in other states do not negate good news in New York, of course. But New York will still have relatively high insurance premiums, because the cost of medical care in the state is among the highest in the country. The Times story was hardly a model of clarity about what is going to happen in New York, and committed some of the apples and oranges kind of sins I have been warning reporters about in their coverage of the exchanges.

Sign up for CJR's daily email

The second graph, for example, reported that “individuals in New York City who now pay $1,000 a month or more for coverage will be able to shop for health insurance for as little as $308 monthly. With federal subsidies, the cost will be even lower.” But what kind of plans is the Times talking about? How old is the person they were comparing rates for? What kind of benefits would people get for $1,000 a month now versus $308 in January? On the New York Department of Financial Services website, which gives approved rates for policies to be sold in the New York exchange, I found New York Fidelus offering a policy for $308.33, a bronze plan sold approved for sale on the exchange for someone in New York City that covers only 60 percent of someone’s medical costs. What is the cost sharing? What is the coinsurance? Is it a high deductible plan? How large a choice of doctors and hospitals does a policyholder have.

To judge how good a deal this is, someone needs to know more than just the premium. And the same goes for the $1,000 plan from this year. What were its benefits and cost-sharing requirements? We don’t have a clue. The Times may have been comparing apples and pomegranates, as so many reporters have done in covering announcements from the state exchanges. It’s just not clear.

In the 13th graph, the Times acknowledges that “while the rates will fall over all, apples-to-apples comparisons are impossible from this year to next because all of the plans are essentially new insurance products.” It might have helped to report this higher in the story–or omit the dramatic, but incomplete and misleading, comparison at the outset.

We know that plans with rock bottom premiums may come with very narrow networks of providers, meaning consumers may have little choice. Insurers are limiting their networks only to those who give the deepest discounts, which enable them to compete with lower prices. The Times did note that cheap plans offered by “newcomers” in the market may have limited networks, but established insurance plans have have narrow networks as well. And the Times did allude to this problem at the end with an anecdotal kicker–some quotes from 46-year-old Jerry Ball from Queens, who now pays nearly $18,000 for a high deductible plan from Oxford. The least expensive Oxford plan offered next year, he says, would cost him about as much as he pays now. According to the state Department of Financial Services, an Oxford HMO–a bronze plan sold outside of the exchange–would cost him $20,175 for the year. Oxford didn’t appear to be offering a bronze plan in the exchange. Ball worried that if he switched carriers, he might also have to switch doctors. “I’m concerned that some of the better doctors aren’t going to take health insurance,” he said. Would Ball be eligible for a subsidy that would send him to the exchange? We don’t know. Again, more vagueness from the paper.

The Times did acknowledge that some people shopping in the exchanges would be eligible for subsidies, but again clarity was lacking. In a graph following a predictable quote from the governor saying that the exchange “will offer the type of real competition that helps drive down health insurance costs,” the paper noted that an individual with an annual income of $17,000 will pay about $55 a month for a silver plan, while someone with an income of $25,000 would pay about $145. The paper did not make clear that these were subsidized rates and picked for its comparison–maybe to emphasize how cheap premiums will be in the New York exchange–only for those with the low incomes. (The higher someone’s income, the lower the subsidy and thus the higher the out-of-pocket costs.) A better comparison might have been to use a family with the median income in New York state, about $57,000.

In fairness, though, the release from the Department of Financial Services was short on details. For example, it didn’t give the full name of the policies it was comparing. Some plans offer more than one. It didn’t give ages of the people who would get the rates it presented. It didn’t tell consumers (or reporters) where they could get the nitty-gritty details of the policies whose rates they were touting. It didn’t explain what it meant for a policy to be on or off the exchange.

The release was a win for the exchange, but not for New Yorkers who need to know much more. It’s too bad the Times didn’t use its stature to lead the way to better reporting about the exchanges. Like so many other news outlets, it passed along only part of a very complicated story.

Follow @USProjectCJR for more posts from Trudy Lieberman and the rest of the United States Project team, including our work on healthcare issues and public health at The Second Opinion. And for Trudy’s resource guide to covering the ins and outs of buying insurance on the state exchanges, see Open Wide, from CJR’s July/August issue.

Related stories:

Exchange Watch: California Dreaming

Exchange Watch: The ongoing game of Spin the Rates

Exchange Watch: Ohio insurance redux

Trudy Lieberman is a longtime contributing editor to the Columbia Journalism Review. She is the lead writer for CJR's Covering the Health Care Fight. She also blogs for Health News Review and the Center for Health Journalism. Follow her on Twitter @Trudy_Lieberman.